Report: 2020 AAI Annual Report
In 2020, BVGH has seen tremendous collaboration and creativity from our many AAI partners, especially in light of the challenges wrought by the COVID-19 pandemic. Now, more than ever, we cannot afford to forget about cancer – especially in low- and middle-income countries where accessing quality cancer care is already so challenging. Read here.
Presentation: 2020 Skoll World ForumBVGH President & CEO, Jennifer Dent, and AAI Partner, Dr. Faruk Mohammed, discuss the steps taken to kick off the pilot drug access program in Nigeria and plans to roll the program out in other countries.
Blog: “We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there.”
We must take the lessons and strategies learned battling cancer in the U.S. and apply them on a larger scale. Global cancer trends are imbalanced. It is time for us to share our successes and create change. Read more.
STAT News Article: “Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that.”
Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed.
Read more.
BVGH’s African Access Initiative featured at the Biden Cancer Summit
BVGH was featured at the Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized cancer epidemic through the African Access Initiative.
Read more.
Video: BVGH presents AAI at Biden Cancer Summit
BVGH has launched the African Access Initiative in partnership with leading pharmaceutical companies, Pfizer and Takeda Pharmaceuticals, and is also working with five African ministries of health including Nigeria, Kenya, Côte d’Ivoire, Cameroon, and Rwanda. Watch here.
Media Contact
Email: info@bvgh.org
Tel: +1 206-880-7778 ext. 104
View Archive
The First 10 Years of WIPO Re:Search
Celebrating the first 10 years of WIPO Re:Search, now spanning over 40 countries. Read about the accomplishments of the partnership and its scientific network of over 150 members, which by sharing resources and expertise is collaborating to improve the global health landscape.
Read more.
2020 BVGH Partnership Hub Annual Report
During the COVID-19 pandemic, WIPO Re:Search is more important than ever in the fight against NTDs, malaria, and tuberculosis. Read more about our partnerships and progress in the 2020 BVGH Partnership Hub Annual Report.
Read more.
Article: IP to Beat TB: How Efforts to Curb Tuberculosis are Being Fueled by a Collaborative IP Ecosystem
US Chamber of Commerce’s Patrick Kilbride discusses the importance of WIPO Re:Search and explains why collaboration and innovation in research are the only way TB will experience a breakthrough in research.
Read more.
McGill Perspectives on Global Health
Canadian investigators partner through WIPO Re:Search to improve diagnosis of Chagas disease-a significant public health problem in Latin America
Read more.
2020 BVGH Partnership Hub Mid-Year Report
During the COVID-19 pandemic, WIPO Re:Search is more important than ever in the fight against NTDs, malaria, and tuberculosis. Read more about our partnerships and progress in the 2020 BVGH Partnership Hub Mid-Year Report.
Read more.
2019 Partnership Hub Annual Report
WIPO Re:Search has come a long way in the eight years since our launch and our commitment to the health of underserved communities has never
wavered. Read more about our partnerships and progress in the 2019 BVGH Partnership Hub Annual Report. Read more.
WIPO Re:Search Partnership Stories 2016-2019
In this publication, BVGH brings to life the WIPO Re:Search portfolio of 155 R&D collaborations focused on improving the prevention, diagnosis, and treatment of some of the world’s most-devastating diseases. The stories show how global cross-sector collaborations are driving R&D for neglected infectious diseases. Read more.
WIPO Re:Search: Advancing Product Development for Neglected Infectious Diseases through Global Public-Private Partnerships
This publication highlights seven exciting drug development collaborations that are advancing solutions to some of the world’s most pernicious diseases. Each featured collaboration has achieved key R&D milestones and has been advanced and de-risked through WIPO Re:Search. Read more.
TropMed Special Edition Book – Prospects for Schistosomiasis Elimination
The Journal of Tropical Medicine and Infectious Disease has published their special edition on schistosomiasis, featuring a BVGH peer-reviewed publication: “WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis.” Read more.
2019 BVGH Partnership Hub Mid-Year Report
BVGH established 14 new collaborations in the first half of 2019, spanning 22 companies and academic/non-profit organizations, 11 countries – 6 of which are disease-endemic – and 7 diseases.
Read more.
TropMed Article: “WIPO Re:Search – Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development”
Through case studies, this article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers to leapfrog their R&D programs by accessing pharmaceutical industry resources. Read more.
2018 WIPO Re:Search Annual Report
Since the Consortium’s launch in 2011, WIPO Re:Search has grown to 140 organizations across 40 countries and boasts a portfolio of 140 R&D collaborations focused on improving the prevention, diagnosis, and treatment of NTDs, malaria, and TB. Read more.
TropMed Article: “WIPO Re:Search – A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis”
Using WIPO Re:Search as an example, this article highlights the opportunities for the public-private partnership model to play a key role in the elimination of schistosomiasis.
Read more.
Book Chapter: “Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships”
BVGH authored chapter in “The Cambridge Handbook of Private-Public Partnerships, Intellectual Property Governance, and Sustainable Development. The full open-access book can be found on Seattle University’s Digital Commons here. Read more.
Access to Medicines Foundation Article: “How to accelerate pharmaceutical R&D – A new framework for sharing IP with global health researchers”
In collaboration with BVGH, the Access to Medicine Foundation has now developed a new framework for evaluating industry IP-sharing agreements for R&D. The framework will be used for the first time as part of the 2018 Access to Medicine Index analysis. Read more.
